Morisseau S - Search Results

1

Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice.

Ladjemi MZ, Chardes T, Corgnac S, Garambois V, Morisseau S, Robert B, Bascoul-Mollevi C, Ait Arsa I, Jacot W, Pouget JP, Pelegrin A, Navarro-Teulon I. Ladjemi MZ, et al. Among authors: morisseau s. Breast Cancer Res. 2011 Feb 4;13(1):R17. doi: 10.1186/bcr2826. Breast Cancer Res. 2011. PMID: 21294885 Free PMC article.

2

In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.

Larbouret C, Robert B, Navarro-Teulon I, Thèzenas S, Ladjemi MZ, Morisseau S, Campigna E, Bibeau F, Mach JP, Pèlegrin A, Azria D. Larbouret C, et al. Among authors: morisseau s. Clin Cancer Res. 2007 Jun 1;13(11):3356-62. doi: 10.1158/1078-0432.CCR-06-2302. Clin Cancer Res. 2007. PMID: 17545543 Free article.

3

Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts.

Larbouret C, Robert B, Bascoul-Mollevi C, Penault-Llorca F, Ho-Pun-Cheung A, Morisseau S, Navarro-Teulon I, Mach JP, Pèlegrin A, Azria D. Larbouret C, et al. Among authors: morisseau s. Ann Oncol. 2010 Jan;21(1):98-103. doi: 10.1093/annonc/mdp496. Epub 2009 Nov 4. Ann Oncol. 2010. PMID: 19889608 Free PMC article.

4

Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein.

Germain C, Campigna E, Salhi I, Morisseau S, Navarro-Teulon I, Mach JP, Pèlegrin A, Robert B. Germain C, et al. Among authors: morisseau s. Protein Eng Des Sel. 2008 Nov;21(11):665-72. doi: 10.1093/protein/gzn047. Epub 2008 Sep 11. Protein Eng Des Sel. 2008. PMID: 18790793 Free PMC article.

5

Emergence of NK Cell Hyporesponsiveness after Two IL-15 Stimulation Cycles.

Frutoso M, Morisseau S, Tamzalit F, Quéméner A, Meghnem D, Leray I, Jacques Y, Mortier E. Frutoso M, et al. Among authors: morisseau s. J Immunol. 2018 Jul 15;201(2):493-506. doi: 10.4049/jimmunol.1800086. Epub 2018 May 30. J Immunol. 2018. PMID: 29848756

6

IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.

Tamzalit F, Barbieux I, Plet A, Heim J, Nedellec S, Morisseau S, Jacques Y, Mortier E. Tamzalit F, et al. Among authors: morisseau s. Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8565-70. doi: 10.1073/pnas.1405514111. Epub 2014 May 27. Proc Natl Acad Sci U S A. 2014. PMID: 24912180 Free PMC article.

7

IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.

Desbois M, Le Vu P, Coutzac C, Marcheteau E, Béal C, Terme M, Gey A, Morisseau S, Teppaz G, Boselli L, Jacques Y, Béchard D, Tartour E, Cassard L, Chaput N. Desbois M, et al. Among authors: morisseau s. J Immunol. 2016 Jul 1;197(1):168-78. doi: 10.4049/jimmunol.1600019. Epub 2016 May 23. J Immunol. 2016. PMID: 27217584

8

Cutting Edge: Differential Fine-Tuning of IL-2- and IL-15-Dependent Functions by Targeting Their Common IL-2/15Rβ/γc Receptor.

Meghnem D, Morisseau S, Frutoso M, Trillet K, Maillasson M, Barbieux I, Khaddage S, Leray I, Hildinger M, Quéméner A, Jacques Y, Mortier E. Meghnem D, et al. Among authors: morisseau s. J Immunol. 2017 Jun 15;198(12):4563-4568. doi: 10.4049/jimmunol.1700046. Epub 2017 May 15. J Immunol. 2017. PMID: 28507024

9

Selective Targeting of IL-15Rα Is Sufficient to Reduce Inflammation.

Meghnem D, Maillasson M, Barbieux I, Morisseau S, Keita D, Jacques Y, Quéméner A, Mortier E. Meghnem D, et al. Among authors: morisseau s. Front Immunol. 2022 May 3;13:886213. doi: 10.3389/fimmu.2022.886213. eCollection 2022. Front Immunol. 2022. PMID: 35592318 Free PMC article.

10

IL-15Rα membrane anchorage in either cis or trans is required for stabilization of IL-15 and optimal signaling.

Quéméner A, Morisseau S, Sousa RP, Trillet K, Maillasson M, Leray I, Jacques Y, Dion J, Barbieux I, Frutoso M, Laurent AD, Le Questel JY, Mortier E. Quéméner A, et al. Among authors: morisseau s. J Cell Sci. 2019 Dec 5;133(5):jcs236802. doi: 10.1242/jcs.236802. J Cell Sci. 2019. PMID: 31653781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters